| European Federation of Internal Medicine

HMPC: overview of assessment work - priority list

Submitted by Anonymous (not verified) on 30 January 2026 - 11:28

HMPC: overview of assessment work - priority list

Read more about HMPC: overview of assessment work - priority list

Committee on Herbal Medicinal Products (HMPC): Work Plan 2026

Submitted by Anonymous (not verified) on 30 January 2026 - 11:25

Committee on Herbal Medicinal Products (HMPC): Work Plan 2026

Read more about Committee on Herbal Medicinal Products (HMPC): Work Plan 2026

Meeting on the impact of chemical and environmental policies on the healthcare sector and availability of medicines, European Medicines Agency, Amsterdam, the Netherlands, 19 December 2025

Submitted by Anonymous (not verified) on 30 January 2026 - 11:10

Meeting on the impact of chemical and environmental policies on the healthcare sector and availability of medicines, European Medicines Agency, Amsterdam, the Netherlands, 19 December 2025

Read more about Meeting on the impact of chemical and environmental policies on the healthcare sector and availability of medicines, European Medicines Agency, Amsterdam, the Netherlands, 19 December 2025

First treatment for rare thymidine kinase 2 deficiency

Submitted by Anonymous (not verified) on 30 January 2026 - 11:01

First treatment for rare thymidine kinase 2 deficiency

Read more about First treatment for rare thymidine kinase 2 deficiency

New medicine to treat chronic graft-versus-host disease

Submitted by Anonymous (not verified) on 30 January 2026 - 11:01

New medicine to treat chronic graft-versus-host disease

Read more about New medicine to treat chronic graft-versus-host disease